vimarsana.com
Home
Live Updates
Cantargia AB: Cantargia's CAN10 demonstrates positive activi
Cantargia AB: Cantargia's CAN10 demonstrates positive activi
Cantargia AB: Cantargia's CAN10 demonstrates positive activity in systemic sclerosis models in new data presented at ACR Convergence 2022
Strongly supports therapeutic potential in one of CAN10's lead indications LUND, Sweden, Nov. 8, 2022 /PRNewswire/ -- Cantargia (Cantargia AB) (Nasdaq Stockholm: CANTA) today reported new
Related Keywords
Stockholm ,
Sweden ,
Germany ,
Philadelphia ,
Pennsylvania ,
United States ,
Prnewswire Cantargia ,
Heinrich Heine University Hiller Research Center ,
Nasdaq Stockholm ,
Systemic Sclerosis ,
Related Disorders ,
Preclinical Models ,
Cantargia ,
An10 ,
Emonstrates ,
Positive ,
Activity ,
Systemic ,
Clerosis ,
Models ,
Data ,
Resented ,
Convergence ,
022 ,